CD73: a new biomarker in triple-negative breast cancer

被引：4
|
作者：
Lafont, Virginie [1 ,2 ]
Michaud, Henri-Alexandre [1 ,2 ]
Bonnefoy, Nathalie [1 ,2 ]
机构：
[1] INSERM, IRCM, Montpellier, France
[2] Univ Montpellier, Inst Reg Canc Montpellier ICM, Montpellier, France
来源：
TRANSLATIONAL CANCER RESEARCH | 2018年 / 7卷
关键词：
CLINICAL-SIGNIFICANCE; POOR-PROGNOSIS; EXPRESSION; CARCINOMA; MIGRATION; CELLS;
D O I：
10.21037/tcr.2018.05.22
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S594 / S596
页数：3
相关论文
共 50 条
  • [41] Notch1 promotes resistance to cisplatin by up-regulating Ecto-5′-nucleotidase (CD73) in triple-negative breast cancer cells
    Qi, Yuzhu
    Li, Meifang
    Li, Shaozhong
    Zeng, De
    Xiao, Yingsheng
    Li, Jiwei
    Ye, Qianqian
    Bremer, Edwin
    Zhang, Guo-jun
    CELL DEATH DISCOVERY, 2023, 9 (01)
  • [42] Androgen receptor as a mediator and biomarker of radioresistance in triple-negative breast cancer
    Speers, Corey
    Zhao, Shuang G.
    Chandler, Ben
    Liu, Meilan
    Wilder-Romans, Kari
    Olsen, Eric
    Nyati, Shyam
    Ritter, Cassandra
    Alluri, Prasanna G.
    Kothari, Vishal
    Hayes, Daniel F.
    Lawrence, Theodore S.
    Spratt, Daniel E.
    Wahl, Daniel R.
    Pierce, Lori J.
    Feng, Felix Y.
    NPJ BREAST CANCER, 2017, 3 : 1 - 10
  • [43] Notch1 promotes resistance to cisplatin by up-regulating Ecto-5′-nucleotidase (CD73) in triple-negative breast cancer cells
    Yuzhu Qi
    Meifang Li
    Shaozhong Li
    De Zeng
    Yingsheng Xiao
    Jiwei Li
    Qianqian Ye
    Edwin Bremer
    Guo-jun Zhang
    Cell Death Discovery, 9
  • [44] Androgen receptor as a mediator and biomarker of radioresistance in triple-negative breast cancer
    Corey Speers
    Shuang G. Zhao
    Ben Chandler
    Meilan Liu
    Kari Wilder-Romans
    Eric Olsen
    Shyam Nyati
    Cassandra Ritter
    Prasanna G. Alluri
    Vishal Kothari
    Daniel F. Hayes
    Theodore S. Lawrence
    Daniel E. Spratt
    Daniel R. Wahl
    Lori J. Pierce
    Felix Y. Feng
    npj Breast Cancer, 3
  • [45] Peroxiporins in Triple-Negative Breast Cancer: Biomarker Potential and Therapeutic Perspectives
    Bijelic, Anita
    Silovski, Tajana
    Mlinaric, Monika
    Gasparovic, Ana Cipak
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (12)
  • [46] TTK is a favorable prognostic biomarker for triple-negative breast cancer survival
    Xu, Qianqian
    Xu, Yali
    Pan, Bo
    Wu, Liangcai
    Ren, Xinyu
    Zhou, Yidong
    Mao, Feng
    Lin, Yan
    Guan, Jinghong
    Shen, Songjie
    Zhang, Xiaohui
    Wang, Changjun
    Zhong, Ying
    Zhou, Liangrui
    Liang, Zhiyong
    Zhao, Haitao
    Sun, Qiang
    ONCOTARGET, 2016, 7 (49) : 81815 - 81829
  • [47] NEW CHOICE FOR TRIPLE-NEGATIVE BREAST CANCER (CHINA)
    Yu, Z.
    Zuo, W.
    Wang, Y.
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (03) : I16 - I17
  • [48] New Therapeutic Strategies for Triple-Negative Breast Cancer
    Szekely, Borbala
    Silber, Andrea L. M.
    Pusztai, Lajos
    ONCOLOGY-NEW YORK, 2017, 31 : 13 - 20
  • [49] New Therapeutic Strategies for Triple-Negative Breast Cancer
    Szekely, Borbala
    Silber, Andrea L. M.
    Pusztai, Lajos
    ONCOLOGY-NEW YORK, 2017, 31 (02): : 130 - 137
  • [50] New Achievements for the Treatment of Triple-Negative Breast Cancer
    Catalano, Alessia
    Iacopetta, Domenico
    Ceramella, Jessica
    Mariconda, Annaluisa
    Rosano, Camillo
    Scumaci, Domenica
    Saturnino, Carmela
    Longo, Pasquale
    Sinicropi, Maria Stefania
    APPLIED SCIENCES-BASEL, 2022, 12 (11):
12345